Filing Details
- Accession Number:
- 0001415889-24-010236
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-03 21:33:32
- Reporting Period:
- 2023-09-01
- Accepted Time:
- 2024-04-03 21:33:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1532346 | Atreca Inc. | BCEL | Pharmaceutical Preparations (2834) | 273723255 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1782758 | Phillips Courtney | C/O Atreca, Inc., 835 Industrial Rd. Suite 400 San Carlos CA 94070 | General Counsel & Secretary | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2023-09-01 | 7,061 | $0.37 | 50,431 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" and does not represent a discretionary trade by the Reporting Person.